Quality of life (QL) in a randomised controlled trial of dose intensified chemotherapy with or without rHuG-CSF (lenograstim) in small cell lung cancer (SCLC)

Lung Cancer ◽  
1994 ◽  
Vol 11 ◽  
pp. 82
The Lancet ◽  
2015 ◽  
Vol 385 (9962) ◽  
pp. 36-42 ◽  
Author(s):  
Ben J Slotman ◽  
Harm van Tinteren ◽  
John O Praag ◽  
Joost L Knegjens ◽  
Sherif Y El Sharouni ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document